Legend Buyout Report Boosts, Validates China Biotech

Another In String Of Recent Deals?

A reported buyout bid for Legend Biotech has delivered a much needed shot of confidence to the Chinese biotech sector, despite not being confirmed. Amid a shifting environment, Hengrui also sees globalization as essential to its future.

Asia globe
Legend buyout offer bolsters China biotech, Hengrui sees going global as essential • Source: Shutterstock

More from China

More from Focus On Asia